Yvonne Naughton | Head of Investor Relations and Corporate Communications |
Anat Cohen-Dayag | President and Chief Executive Officer |
Alberto Sessa | Chief Financial Officer |
Henry Adewoye | Chief Medical Officer |
Eran Ophir | Senior Vice President, Research and Drug Discovery |
Mark Breidenbach | Oppenheimer & Co. Inc. |
Stephen Willey | Stifel Financial Corp. |
Asthika Goonewardene | Truist Securities |
Daina Graybosch | SVB Securities |
Ladies and gentlemen, thank you for joining us today. Welcome to Compugen’s First Quarter 2023 Results Conference Call. At this time, all participants are in a listen-only mode. An audio webcast of this call is available in the Investors section of Compugen’s website, www.cgen.com.
As a reminder, today’s call is being recorded.